Clinical Trial Update: Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating DIDALA monotherapy versus metformin in type 2 diabetes, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DIDALA
• metformin (metformin)

Snippet

Sponsor: Centre of Clinical Pharmacology, Hanoi Medical University | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN